These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 11770701

  • 1. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.
    Gladysheva IP, Moroz NA, Karmakova TA, Nemtsova ER, Yakubovskaya RI, Larionova NI.
    J Drug Target; 2001; 9(5):303-16. PubMed ID: 11770701
    [Abstract] [Full Text] [Related]

  • 2. Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor.
    Gladysheva IP, Polekhina OV, Karmakova TA, Nemtsova ER, Yakubovskaya RI, Shen WC, Kennedy AR, Larionova NI.
    J Control Release; 2001 Jul 06; 74(1-3):303-8. PubMed ID: 11489510
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops.
    Mao Y, Lai C, Vogtentanz G, Schmidt B, Day T, Miller J, Brandon DL, Chen D.
    Protein J; 2005 Jul 06; 24(5):275-82. PubMed ID: 16284725
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.
    Larionova NI, Gladysheva IP, Polekhina OV, Kurochkina LP, Gorbatova EN.
    Appl Biochem Biotechnol; 1996 Jul 06; 61(1-2):139-48. PubMed ID: 9100351
    [Abstract] [Full Text] [Related]

  • 5. Soybean bowman--birk inhibitor conjugates with clinical dextran. synthesis and antiproteolytic activity.
    Gladysheva IP, Moroz NA, Papisova AI, Larionova NI.
    Biochemistry (Mosc); 2001 Apr 06; 66(4):384-9. PubMed ID: 11403644
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H, Kennedy AR, Witschi H, Shen WC.
    J Drug Target; 1993 Apr 06; 1(1):41-9. PubMed ID: 8069543
    [Abstract] [Full Text] [Related]

  • 10. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A, Domoney C.
    Curr Protein Pept Sci; 2006 Jun 06; 7(3):201-16. PubMed ID: 16787260
    [Abstract] [Full Text] [Related]

  • 11. [Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide].
    Larionova NI, Gladysheva IP, Topchieva IN, Kazanskaia NF.
    Biokhimiia; 1993 Oct 06; 58(10):1658-64. PubMed ID: 8268307
    [Abstract] [Full Text] [Related]

  • 12. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 06; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
    Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z.
    J Cancer Res Ther; 2021 Dec 06; 17(2):504-509. PubMed ID: 34121699
    [Abstract] [Full Text] [Related]

  • 15. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999 Dec 06; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
    Billings PC, Brandon DL, Habres JM.
    Eur J Cancer; 1991 Dec 06; 27(7):903-8. PubMed ID: 1834126
    [Abstract] [Full Text] [Related]

  • 19. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean.
    Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A.
    J Biochem Mol Toxicol; 2019 Dec 06; 33(12):e22406. PubMed ID: 31593353
    [Abstract] [Full Text] [Related]

  • 20. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 06; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.